In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.

Approval was based on data from the Phase III NextCOVE trial, which demonstrated that mNEXSPIKE met non-inferiority criteria ...

Major players including AbbVie, GSK, Sanofi, and Eli Lilly recently bolstered their R&D pipelines with a wave of acquisitions ...

Under terms of the deal, both companies will co-develop and co-commercialize BNT327 for multiple solid tumors, with the ...

A Harvard Business School Healthcare Alumni Association Q&A with Aileen Fernandes, Chief Business Officer of Arcellx.

The pharmaceutical company will donate money for each strike-out made by the team’s pitcher for the remainder of the regular ...

The CDC Foundation is expanding a youth healthcare program to rural areas. Young people living in rural areas in Georgia, ...

The GMRLN plays an important role in identifying outbreaks early and providing the necessary support to control them.

The organization is providing trainers with information and education for how to coach clients taking the weight-loss ...

Arkstone's study suggests that AI can produce faster therapeutic recommendations than traditional methods. According to ...